Marco Rusnati
Marco Rusnati
Department of Molecular and Translational Medicine, University of Brescia
Verified email at - Homepage
Cited by
Cited by
Fibroblast growth factor/fibroblast growth factor receptor system in angiogenesis
M Presta, P Dell’Era, S Mitola, E Moroni, R Ronca, M Rusnati
Cytokine & growth factor reviews 16 (2), 159-178, 2005
Internalization of HIV-1 tat requires cell surface heparan sulfate proteoglycans
M Tyagi, M Rusnati, M Presta, M Giacca
Journal of Biological Chemistry 276 (5), 3254-3261, 2001
Complexity and complementarity of outer membrane protein A recognition by cellular and humoral innate immunity receptors
P Jeannin, B Bottazzi, M Sironi, A Doni, M Rusnati, M Presta, V Maina, ...
Immunity 22 (5), 551-560, 2005
Selective recognition of fibroblast growth factor-2 by the long pentraxin PTX3 inhibits angiogenesis
M Rusnati, M Camozzi, E Moroni, B Bottazzi, G Peri, S Indraccolo, ...
Blood 104 (1), 92-99, 2004
Role of the soluble pattern recognition receptor PTX3 in vascular biology
M Presta, M Camozzi, G Salvatori, M Rusnati
Journal of cellular and molecular medicine 11 (4), 723-738, 2007
HIV-tat protein is a heparin-binding angiogenic growth factor.
A Albini, R Benelli, M Presta, M Rusnati, M Ziche, A Rubartelli, ...
Oncogene 12 (2), 289-297, 1996
Endogenous basic fibroblast growth factor is implicated in the vascularization of the chick embryo chorioallantoic membrane
D Ribatti, C Urbinati, B Nico, M Rusnati, L Roncali, M Presta
Developmental biology 170 (1), 39-49, 1995
αvβ3 Integrin Mediates the Cell-adhesive Capacity and Biological Activity of Basic Fibroblast Growth Factor (FGF-2) in Cultured Endothelial Cells
M Rusnati, E Tanghetti, P Dell’Era, A Gualandris, M Presta
Molecular Biology of the Cell 8 (12), 2449-2461, 1997
Fibroblast growth factors (FGFs) in cancer: FGF traps as a new therapeutic approach
M Presta, P Chiodelli, A Giacomini, M Rusnati, R Ronca
Pharmacology & therapeutics 179, 171-187, 2017
Fibroblast growth factors/fibroblast growth factor receptors as targets for the development of anti-angiogenesis strategies
M Rusnati, M Presta
Current pharmaceutical design 13 (20), 2025-2044, 2007
Basic fibroblast growth factor–induced angiogenic phenotype in mouse endothelium: a study of aortic and microvascular endothelial cell lines
M Bastaki, EE Nelli, P Dell’Era, M Rusnati, MP Molinari-Tosatti, S Parolini, ...
Arteriosclerosis, thrombosis, and vascular biology 17 (3), 454-464, 1997
Basic fibroblast growth factor is released from endothelial extracellular matrix in a biologically active form
M Presta, JAM Maier, M Rusnati, G Ragnotti
Journal of cellular physiology 140 (1), 68-74, 1989
Multiple interactions of HIV-I Tat protein with size-defined heparin oligosaccharides
M Rusnati, G Tulipano, D Spillmann, E Tanghetti, P Oreste, G Zoppetti, ...
Journal of Biological Chemistry 274 (40), 28198-28205, 1999
Dendritic cell–endothelial cell cross-talk in angiogenesis
S Sozzani, M Rusnati, E Riboldi, S Mitola, M Presta
Trends in immunology 28 (9), 385-392, 2007
Cutting edge: proangiogenic properties of alternatively activated dendritic cells
E Riboldi, T Musso, E Moroni, C Urbinati, S Bernasconi, M Rusnati, ...
The Journal of Immunology 175 (5), 2788-2792, 2005
The basic domain in HIV-1 Tat protein as a target for polysulfonated heparin-mimicking extracellular Tat antagonists
M Rusnati, G Tulipano, C Urbinati, E Tanghetti, R Giuliani, M Giacca, ...
Journal of Biological Chemistry 273 (26), 16027-16037, 1998
Basic Fribroblast Growth Factor Overexpression in Endothelial Cells: An Autocrine Mechanism for Angiogenesis and Angioproliferative Diseases
A Gualandris, M Rusnati, M Bastaki, M Ziche, M Presta
Vascular Endothelium: Pharmacologic and Genetic Manipulations, 263-264, 1998
Interaction of angiogenic basic fibroblast growth factor with endothelial cell heparan sulfate proteoglycans: biological implications in neovascularization
M Rusnati, M Presta
International Journal of Clinical and Laboratory Research 26, 15-23, 1996
Heparin/Heparan sulfate proteoglycans glycomic interactome in angiogenesis: biological implications and therapeutical use
P Chiodelli, A Bugatti, C Urbinati, M Rusnati
Molecules 20 (4), 6342-6388, 2015
Heparin derivatives as angiogenesis inhibitors
M Presta, D Leali, H Stabile, R Ronca, M Camozzi, L Coco, E Moroni, ...
Current pharmaceutical design 9 (7), 553, 2003
The system can't perform the operation now. Try again later.
Articles 1–20